Related Experiment Videos
Disposition of anticonvulsants in childhood
1Department of Pharmacology and Therapeutics, University of Wales College of Medicine, Cardiff, United Kingdom.
Insights
Understanding childhood epilepsy and anticonvulsant pharmacokinetics is crucial. Age significantly impacts drug levels, necessitating tailored dosing to avoid under or overdosing in children.
Area of Science:
- Pediatric Neurology
- Clinical Pharmacology
Background:
- Recent advances in understanding childhood epilepsies.
- Growing awareness of anticonvulsant drug pharmacokinetics.
Purpose of the Study:
- To provide an overview of anticonvulsant drug pharmacokinetic properties.
- To emphasize findings specific to pediatric populations.
Main Methods:
- Review of pharmacokinetic parameters of anticonvulsant drugs.
- Analysis of age-related physiological variables influencing drug disposition.
Main Results:
- Pharmacokinetic parameters are not constant and vary with age.
- Age is a major determinant of pharmacokinetic variability.
- Dosage regimens require age-specific adjustments.
Conclusions:
- Dosage adjustments are essential for different age groups to prevent dosing errors.
- Understanding monitoring limitations is key for effective therapeutic drug monitoring.
Abstract:
There have been great advances in our understanding of the childhood epilepsies within recent years and at the same time there has been increasing awareness of the pharmacokinetic properties of the anticonvulsant drugs. It has been increasingly recognised that pharmacokinetic parameters of anticonvulsants are not constant, but are subject to influences by a number of physiological variables over which age is a major determinant. As changes in pharmacokinetic parameters will alter dosage requirements, dosage regimens cannot be transferred from one age group to another without the risk of underdosing or overdosing. Drug monitoring techniques are being increasingly used as a guide to correct dosing but knowledge of the limitations of monitoring is as important as knowledge of potential benefits for monitoring to be used correctly. An overview of the important pharmacokinetic properties of anticonvulsant drugs is provided, with emphasis on findings in children where such data are available.